MRI of rabbit atherosclerosis in response to dietary cholesterol lowering.

Direct imaging of the atherosclerotic plaque, rather than the angiographic lumen, may provide greater insight into the response of atherosclerosis to cholesterol-lowering therapy. Aortic plaque was studied in vivo by MRI in rabbits undergoing dietary cholesterol intervention. Thirty-one rabbits underwent aortic balloon injury and high-cholesterol diet for 4 months and then were assigned to low-cholesterol versus continued high-cholesterol diet for up to an additional 16 months. High-resolution (310 micrometer) fast spin-echo MRI of the abdominal aorta was performed at 4, 12, and 20 months and compared with histology. MRI demonstrated a significant reduction in % area stenosis in rabbits placed on low-cholesterol diet (44.6+/-2. 1% at 20 months versus 55.8+/-1.5% at 4 months, P=0.0002). In contrast, % area stenosis increased in rabbits maintained on high-cholesterol diet (69.8+/-3.8% at 20 months versus 55.8+/-1.5% at 4 months, P=0.001). Similarly, plaque thickness decreased significantly in the low-cholesterol group (0.60+/-0.05 mm at 20 months versus 0.85+/-0.06 mm at 4 months, P=0.006), with a trend toward increase in the high-cholesterol group (1.02+/-0.08 mm at 20 months versus 0.85+/-0.06 mm at 4 months, P=0.1). Thus, in rabbits undergoing dietary cholesterol lowering, MRI detected regression of aortic atherosclerotic plaque in vivo. Plaque progression was seen with maintenance of high-cholesterol diet. MRI is a promising noninvasive technology for directly imaging atherosclerosis and its response to therapeutic interventions.

[1]  Ames,et al.  PREVENTION OF CORONARY HEART DISEASE WITH PRAVASTATIN IN MEN WITH HYPERCHOLESTEROLEMIA , 2000 .

[2]  E A Fisher,et al.  Noninvasive In vivo high-resolution magnetic resonance imaging of atherosclerotic lesions in genetically engineered mice. , 1998, Circulation.

[3]  P. Libby,et al.  Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: a potential mechanism of lesion stabilization. , 1998, Circulation.

[4]  E Atalar,et al.  Intravascular magnetic resonance imaging of aortic atherosclerotic plaque composition. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[5]  E. Braunwald Shattuck lecture--cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. , 1997, The New England journal of medicine.

[6]  T P Trouard,et al.  MRI and NMR spectroscopy of the lipids of atherosclerotic plaque in rabbits and humans , 1997, Magnetic resonance in medicine.

[7]  V. Fuster,et al.  Water diffusion properties of human atherosclerosis and thrombosis measured by pulse field gradient nuclear magnetic resonance. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[8]  V. Fuster,et al.  Magnetic resonance images lipid, fibrous, calcified, hemorrhagic, and thrombotic components of human atherosclerosis in vivo. , 1996, Circulation.

[9]  Richard T. Lee,et al.  Imaging atherosclerosis: lesion vs. lumen , 1996 .

[10]  P. Macfarlane,et al.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia , 1995 .

[11]  V. Fuster,et al.  T2-weighted contrast for NMR characterization of human atherosclerosis. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[12]  L. Hedlund,et al.  MR Microscopy of the Rat Carotid Artery after Balloon Injury by Using an Implanted Imaging Coil , 1995, Magnetic resonance in medicine.

[13]  P. Libby Molecular bases of the acute coronary syndromes. , 1995, Circulation.

[14]  Chun Yuan,et al.  Serial magnetic resonance imaging of experimental atherosclerosis detects lesion fine structure, progression and complications in vivo , 1995, Nature Medicine.

[15]  P. Libby Lesion versus lumen , 1995, Nature Medicine.

[16]  Scandinavian Simvastatin Survival Study Group Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) , 1994, The Lancet.

[17]  R M Henkelman,et al.  Intravascular MR imaging in a porcine animal model , 1994, Magnetic resonance in medicine.

[18]  J. Stengård,et al.  Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease , 1994, The Lancet.

[19]  T K Foo,et al.  Techniques for high‐resolution MR imaging of atherosclerotic plaque , 1994, Journal of magnetic resonance imaging : JMRI.

[20]  A. Yeung,et al.  Functional significance of intimal thickening as detected by intravascular ultrasound early and late after cardiac transplantation. , 1993, Circulation.

[21]  J. Pauly,et al.  Characterization of atherosclerosis with a 1.5‐T imaging system , 1993, Journal of magnetic resonance imaging : JMRI.

[22]  V. Fuster,et al.  The pathogenesis of coronary artery disease and the acute coronary syndromes (2). , 1992, The New England journal of medicine.

[23]  J. Pearlman,et al.  Nuclear Magnetic Resonance Microscopy of Atheroma in Human Coronary Arteries , 1991, Angiology.

[24]  J J Albers,et al.  Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. , 1990, The New England journal of medicine.

[25]  R. Edelman,et al.  Clinical magnetic resonance imaging , 1990 .

[26]  W. Santamore,et al.  Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease? , 1988, Circulation.

[27]  V. Fuster,et al.  Angiographic progression of coronary artery disease and the development of myocardial infarction. , 1988, Journal of the American College of Cardiology.

[28]  M J Davies,et al.  Plaque fissuring--the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. , 1985, British heart journal.